ArticleDrug design, development and therapy2018

Vitexin protects dopaminergic neurons in MPTP-induced Parkinson's disease through PI3K/Akt signaling pathway.

Ming Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.